Cytoskeletal-associated proteins play an active role in coordinating the adhesion and migration machinery in cancer progression, and targeting annexin A2 could effectively inhibit tumor cell adhesion, migration and in vivo grafting (Staquicini et al., 2017). This evidence concerns the gene ANXA2 and neoplasm.